Literature DB >> 8284691

Interleukin-2 therapy after autologous bone marrow transplantation for hematologic malignancies.

A Fefer1, M C Benyunes, C Massumoto, C Higuchi, A York, C D Buckner, J A Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8284691

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

1.  Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.

Authors:  Beverly J Lange; Richard K Yang; Jacek Gan; Jaquelyn A Hank; Eric L Sievers; Todd A Alonzo; Robert B Gerbing; Paul M Sondel
Journal:  Pediatr Blood Cancer       Date:  2011-06-16       Impact factor: 3.167

Review 2.  Role of interleukin-2 in human hematological malignancies.

Authors:  A Toren; A Ackerstein; S Slavin; A Nagler
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

Review 3.  Role of immunotherapy in stem cell transplantation.

Authors:  Sally Arai; Hans G Klingemann
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.